VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Activity
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

26 hedge funds and large institutions have $4.26M invested in Vyant Bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$554K
2
PCM
2
Perkins Capital Management
Minnesota
$1.34M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$702K
4
VF
4
Virtu Financial
New York
$47K
5
Citadel Advisors
5
Citadel Advisors
Florida
$34K

Top Sellers

1
SCM
1
Stonepine Capital Management
Oregon
$639K
2
FCM
2
Fairbanks Capital Management
California
$233K
3
CS
3
Credit Suisse
Switzerland
$0
4
PAM
4
Panagora Asset Management
Massachusetts
$40K
5
UBS Group
5
UBS Group
Switzerland
$4K
Name Market Value Shares Shares
Change 		Shares
Change %
CS
26
Credit Suisse
Switzerland
– – -10,090 Closed
SEI Investments
27
SEI Investments
Pennsylvania
– – -5,000 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Barclays
29
Barclays
United Kingdom
$0 454 – –
1
2